Medically reviewed by DietsMD Board-Certified Physicians, Obesity Medicine
If you've been researching semaglutide, you've likely encountered both Ozempic and Wegovy. Both are made by Novo Nordisk, both contain semaglutide, and both are weekly injections — so what's actually different? The answer comes down to dose, FDA approval, and intended use.
Q: What is the difference between Ozempic and Wegovy?
A: Both Ozempic and Wegovy contain semaglutide, but they differ in dose and FDA approval. Wegovy is approved for chronic weight management at a maximum dose of 2.4mg weekly. Ozempic is approved for type 2 diabetes at lower doses (up to 2.0mg weekly). Wegovy is the appropriate formulation for weight loss treatment.
Side-by-Side Comparison
Wegovy (semaglutide for weight loss):
- FDA-approved for: Chronic weight management in adults with obesity or overweight with comorbidities
- Maximum dose: 2.4mg weekly
- Titration: 0.25mg → 0.5mg → 1.0mg → 1.7mg → 2.4mg (over ~16 weeks)
- Approved: June 2021
- Also approved for: Adolescents 12+ with obesity (2022)
Ozempic (semaglutide for diabetes):
- FDA-approved for: Type 2 diabetes management and cardiovascular risk reduction
- Maximum dose: 2.0mg weekly
- Titration: 0.25mg → 0.5mg → 1.0mg → 2.0mg
- Approved: December 2017
- Frequently prescribed off-label for weight loss
Q: Can Ozempic be used for weight loss?
A: Yes — Ozempic is frequently prescribed off-label for weight loss, and it does produce significant weight loss. However, Wegovy is the FDA-approved formulation for weight management and reaches a higher maximum dose (2.4mg vs. 2.0mg), which is associated with greater average weight loss.
Why the Dose Difference Matters
The higher maximum dose of Wegovy (2.4mg vs. 2.0mg) is clinically meaningful. The STEP trials showed a dose-response relationship — higher doses produce greater appetite suppression and weight loss. The 2.4mg dose was specifically studied and approved for weight management because it produces the best weight loss outcomes.
Which Should You Use for Weight Loss?
For weight loss specifically, Wegovy is the FDA-approved and clinically appropriate choice. It reaches a higher dose, is specifically studied for weight management, and is the formulation your physician will prescribe for this indication. Ozempic may be appropriate in certain clinical situations — your DietsMD physician will determine the best approach for your specific needs.
What About Insurance Coverage?
Insurance coverage differs between the two. Ozempic is more commonly covered for patients with type 2 diabetes. Wegovy coverage for weight loss is improving but remains inconsistent. DietsMD programs don't require insurance — contact us for current pricing.
Q: Is Wegovy stronger than Ozempic?
A: Wegovy reaches a higher maximum dose (2.4mg vs. 2.0mg for Ozempic) and is specifically formulated and approved for weight management. At equivalent doses, the active ingredient (semaglutide) is identical — the difference is in the approved maximum dose and intended clinical use.
→ Complete GLP-1 Weight Loss Guide: Semaglutide & Tirzepatide
→ Tirzepatide vs. Semaglutide: Which Is Right for You?
→ Get your semaglutide prescription at DietsMD →
Medically reviewed by DietsMD board-certified physicians. Information based on current FDA prescribing information for Wegovy and Ozempic.
